Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor

Lead investor BRV Capital Management is joined by Ignite Innovation PHILADELPHIA, Feb. 28, 2023 -- (Healthcare Sales & Marketing Network) -- Verismo Therapeutics, a clinical-stage CAR T company, Penn spinout, and pioneer of the novel KIR-CAR platform t... Biopharmaceuticals, Venture Capital Verismo Therapeutics, KIR-CAR, CAR T-cell therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news